Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: Review of current imaging modalities

Skeletal Radiology

Volumn 27, Issue 2, 1998, Pages 57-71

  Van Der Woude, Henk Jan ^a   Bloem, Johan L ^a   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone neoplasm; Bone tumour; Chemotherapy; Ewing's sarcoma; Imaging; Osteogenic sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC IMAGING; EWING SARCOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PATIENT MONITORING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW;

BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; SARCOMA, EWING'S; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0031943099     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560050339     Document Type: Review

References (62)

1. Huvos AG. Bone tumours, diagnosis, treatment and prognosis. Philadelphia: WB Saunders, 1991:85-155.
2. Fletcher BD. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR 1991; 157:825-833.
3. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumour to preoperative chemotherapy. Cancer 1982; 49:1221-1230.
4. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumour response. J Clin Oncol 1988; 6:329-337.
5. Jürgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone; a 6-year experience of a European Cooperative Trial. Cancer 1988; 61:23-32.
6. Meyers PA, Heller G, Healy J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992; 10:5-15.
7. Petrilli AS, Gentil FC, Epelman S, et al. Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 1991; 68:733-737.
8. Pastorino U, Gasparini M, Tavecchio L, et al. The contribution of salvage surgery to the management of childhood osteosarcoma. J Clin Oncol 1991; 9:1357-1362.
9. Granowetter L. Ewing's sarcoma and extracranial primitive neuroectodermal tumours. Curr Opin Oncol 1992; 4:696-703.
10. Barbieri E, Emiliani E, Zini G, et al. Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients. Int J Radiat Oncol Biol Phys 1990; 19:1165-1170.
11. Jürgens H, Dunst J, Göbel U, et al. Improved survival in Ewing's sarcoma with response based local therapy and intensive chemotherapy (abstract). Proc Am Soc Clin Oncol 1991; 10:316.
12. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32 MIC2. Am J Pathol 1991; 139:317-325.
13. Stephenson CF, Bridge JA, Sandberg AA. Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumours. Hum Pathol 1992; 23:1270-1277.
14. Enneking WF. Musculoskeletal tumor society: staging of musculoskeletal neoplasms. Skeletal Radiol 1985; 13:183-194.
15. Bloem JL, Taminiau AHM, Eulderink F, Hermans J, Pauwels EKJ. Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography, and CT correlated with pathologic examination. Radiology 1988; 169:805-810.
16. Bloem JL, Holscher HC, Taminiau AHM. Magnetic resonance imaging and computed tomography of primary musculoskeletal tumours. In: Bloem JL, Sartoris D, eds. MR imaging and CT of the muskuloskeletal system. Baltimore: Williams & Wilkins, 1992.
17. Carrasco CH, Charnsangavej C, Raymond AK, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology 1989; 170:839-842.
18. Sundaram M, McGuire MH, Herbold DR, Wolverson MK, Heiberg E. Magnetic resonance imaging in planning limb-salvage surgery for primary malignant tumours of bone. J Bone Joint Surg Am 1986; 68:809-819.
19. Gillespy T, Manfrini M, Ruggieri P, Spanier SS, Pettersson H, Springfield DS. Staging of intraosseous extent of osteosarcoma: correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology 1988; 167:765-767.
20. Pettersson H, Gillespy T III, Hamlin DJ, et al. Primary musculoskeletal tumours: examination with MR imaging compared with conventional modalities. Radiology 1987; 164:237-241.
21. Mirowitz SA, Apicella P, Reinus WR, Hammerman AM. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR 1994; 162:215-222.
22. Bloem JL, Van der Woude HJ, Geirnaerdt M, Hogendoorn PCW, Taminiau AHM, Hermans J. Does magnetic resonance imaging make a difference for patients with musculoskeletal sarcoma? Br J Radiol 1997; 70:327-337.
23. Panicek DM, Gatsonis C, Rosenthal DI, et al. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: report of the radiology diagnostic oncology group. Radiology 1997; 202:237-246.
24. Lang P, Grammp S, Vahlensieck M, et al. Primary bone tumours: value of MR angiography for preoperative planning and monitoring response to chemotherapy. AJR 1995;165:135-142.
25. Shuman WP, Patten RM, Baron RL, Liddell RM, Conrad EU, Richardson ML. Comparison of STIR and spin-echo MR imaging at 1.5 T in 45 suspected extremity tumours: lesion conspicuity and extent. Radiology 1991; 179:247-252.
26. Seeger LL, Widoff BE, Bassett LW, Rosen G, Eckardt JJ. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR 1991; 157:347-351.
27. Lang P, Honda G, Roberts T, et al. Musculoskeletal neoplasm: perineoplastic oedema versus tumour on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 1995; 197:831-839.
28. Van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AHM, Nooy MA, Hogendoorn PCW. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumour before surgery. AJR 1995; 165:593-598.
29. Reddick WE, Bhargava R, Taylor JS, Meyer WH, Fletcher BD. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 1995; 5:689-694.
30. Pathria MN. Follow-up of musculoskeletal tumours. In: Syllabus for the categorial course on imaging of cancers. Reston, Va: American College of Radiology, 1992.
31. Salzer-Kuntschik M, Delling G, Beron G, Sigmund R. Morphological grades of regression in osteosarcoma after polychemotherapy-study COSS 80. J Cancer Res Clin Oncol 1983; 106 [Suppl]:21-24.
32. Picci P, Bougraff BT, Bacci G, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 1993; 11:1763-1769.
33. Van der Woude HJ, Bloem JL, Taminiau AHM, Nooy MA, Hogendoorn PCW. Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone. Skeletal Radiol 1994; 23:501-507.
34. Picci P, Bacci G, Campanacci M, et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy: regional mapping of viable and nonviable tumour. Cancer 1985; 56:1515-1521.
35. Misdorp W, Hart G, Delemarre JFM, Voûte PA, van der Eijken JW. An analysis of spontaneous and chemotherapy-associated changes in skeletal osteosarcomas. J Pathol 1988; 156:119-128.
36. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31:567-572.
37. Smith J, Heelan RT, Huvos AG, et al. Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiology 1982; 143:355-360.
38. Holscher HC, Hermans J, Nooy MA, Taminiau AHM, Hogendoorn PCW, Bloem JL. Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma? Skeletal Radiol 1996; 25:19-24.
39. Ehara S, Kattapuram SV, Egglin TK. Ewing's sarcoma: radiographic pattern of healing and bony complications in patients with long-term survival. Cancer 1991; 68:1531-1535.
40. Erlemann R, Sciuk J, Bosse A, et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 1990; 175:791-796.
41. Van der Woude HJ, Bloem JL, Schipper J, et al. Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy. Radiology 1994; 191:421-431.
42. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumour regression during preoperative chemotherapy of osteosarcoma. Skeletal Radiol 1990; 19:165-172.
43. Estes DN, Magill HL, Thompson EI, Hayes FA. Primary Ewing sarcoma: follow-up with Ga-67 scintigraphy. Radiology 1990; 177:449-453.
44. Ohtomo K, Terui S, Yokoyama R, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med 1996; 37:1444-1448.
45. Garcia JR, Kim E, Wong FCL, et al. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas. J Nucl Med 1996; 37:1476-1479.
46. Jones DN, McCowage GB, Sostman HD, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996; 37:1438-1444.
47. Vanel D, Contesso G, Couanet D, Piekarski JD, Sarrazin D, Masselot J. Computed tomography in the evaluation of 41 cases of Ewing's sarcomas. Skeletal Radiol 1982; 9:8-13.
48. Mail JT, Cohen MD, Mirkin LD, Provisor AJ. Response of osteosarcoma to preoperative intravenous high-dose methotrexate chemotherapy: CT evaluation. AJR 1985; 144:89-93.
49. Holscher HC, Bloem JL, van der Woude HJ, et al. Can MRI predict the histopathologic response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 1995; 50: 884-890.
50. Pan G, Raymond AK, Carrasco CH, et al. Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology 1990; 174:517-526.
51. Holscher HC, Bloem JL, Vanel D, et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 1992; 182:839-844.
52. Holscher HC, Bloem JL, Nooy MA, Taminiau AHM, Eulderink F, Hermans J. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. AJR 1990; 154:763-769.
53. Lawrence JA, Babyn PS, Chan HSL, Thorner PS, Pron GE, Krajbich IJ. Extremity osteosaroma in childhood: prognostic value of radiologic imaging. Radiology 1993; 189:43-47.
54. Lemmi MA, Fletcher BD, Marina NM, et al. Use of MR imaging to assess results of chemotherapy for Ewing sarcoma. AJR 1990; 155:343-346.
55. MacVicar AD, Olliff JFC, Pringle J, Ross Pinkerton C, Husband JES. Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. Radiology 1992; 184:859-864.
56. Van der Woude HJ, Bloem JL, Holscher HC, et al. Monitoring the effect of chemotherapy in Ewing sarcoma of bone with MR imaging. Skeletal Radiol 1994; 23:493-500.
57. Hanna SL, Fletcher BD, Parham DM, Bugg MF. Muscle oedema in musculoskeletal tumours: MR imaging characteristics and clinical significance. J Magn Reson Imaging 1991; 1:441-449.
58. de Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, di Paola M. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185:587-592.
59. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumours: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992; 184:243-248.
60. Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging: parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
61. 31P magnetic resonance spectroscopy. Magn Reson Med 1992; 27:226-237.
62. Van der Woude HJ, Bloem JL, Van Oostayen JA, et al. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting final histopathologic response. AJR 1995; 165:125-133.